Taiwan: A recent study in Scientific Reports has revealed that co-administration of metformin and sodium-glucose co-transporter 2 (SGLT2) inhibitors delays the progression of diabetic retinopathy (DR).
Medications are among the lesser-known yet common causes of weight gain. Switching over to a lesser weight-promoting alternative can help to solve the issue of weight gain with medications.